S Žerjav

414 total citations
28 papers, 350 citations indexed

About

S Žerjav is a scholar working on Epidemiology, Virology and Infectious Diseases. According to data from OpenAlex, S Žerjav has authored 28 papers receiving a total of 350 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Epidemiology, 15 papers in Virology and 13 papers in Infectious Diseases. Recurrent topics in S Žerjav's work include HIV Research and Treatment (15 papers), HIV/AIDS Research and Interventions (9 papers) and Hepatitis C virus research (9 papers). S Žerjav is often cited by papers focused on HIV Research and Treatment (15 papers), HIV/AIDS Research and Interventions (9 papers) and Hepatitis C virus research (9 papers). S Žerjav collaborates with scholars based in Serbia, Czechia and Vietnam. S Žerjav's co-authors include Djordje Jevtović, Dubravka Salemović, Jovan Ranin, Olgica Djurković–Djaković, Maja Stanojević, Lazar Markovic, Sonja Vesić, Valentina Nikolić, Tanja Jovanović and Anna Papa and has published in prestigious journals such as Journal of Hepatology, Biomedicine & Pharmacotherapy and Journal of Molecular Medicine.

In The Last Decade

S Žerjav

28 papers receiving 333 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S Žerjav Serbia 11 206 144 109 82 71 28 350
Dubravka Salemović Serbia 10 179 0.9× 191 1.3× 145 1.3× 93 1.1× 27 0.4× 41 379
Nagalingeswaran Kumarasamy India 9 156 0.8× 76 0.5× 55 0.5× 65 0.8× 31 0.4× 15 308
Gaetano Maffongelli Italy 13 162 0.8× 263 1.8× 85 0.8× 54 0.7× 52 0.7× 29 427
Vincent Jeantils France 11 263 1.3× 252 1.8× 116 1.1× 78 1.0× 121 1.7× 22 461
Ingrid Steffen Switzerland 9 233 1.1× 146 1.0× 76 0.7× 36 0.4× 90 1.3× 15 418
Ralph‐Sydney Mboumba Bouassa France 12 217 1.1× 193 1.3× 84 0.8× 46 0.6× 23 0.3× 38 382
Elizabeth Race United States 5 225 1.1× 244 1.7× 165 1.5× 92 1.1× 15 0.2× 5 396
G. Antonucci Italy 12 495 2.4× 294 2.0× 106 1.0× 107 1.3× 337 4.7× 36 655
Margaret J. Gorensek United States 8 155 0.8× 59 0.4× 48 0.4× 56 0.7× 18 0.3× 14 306
Frederikke F. Rönsholt Denmark 10 134 0.7× 156 1.1× 123 1.1× 58 0.7× 8 0.1× 24 411

Countries citing papers authored by S Žerjav

Since Specialization
Citations

This map shows the geographic impact of S Žerjav's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Žerjav with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Žerjav more than expected).

Fields of papers citing papers by S Žerjav

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S Žerjav. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Žerjav. The network helps show where S Žerjav may publish in the future.

Co-authorship network of co-authors of S Žerjav

This figure shows the co-authorship network connecting the top 25 collaborators of S Žerjav. A scholar is included among the top collaborators of S Žerjav based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S Žerjav. S Žerjav is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stanojević, Maja, Dubravka Salemović, S Žerjav, et al.. (2014). Ten Years Survey of Primary HIV-1 Resistance in Serbia: The Occurrence of Multiclass Resistance. AIDS Research and Human Retroviruses. 30(7). 634–641. 13 indexed citations
2.
Salemović, Dubravka, Djordje Jevtović, S Žerjav, et al.. (2014). Tracing the origin and dynamics of the HIV-1 epidemic in Serbia. Archives of Biological Sciences. 66(2). 507–515. 1 indexed citations
3.
Nikolić, Valentina, Dubravka Salemović, Djordje Jevtović, et al.. (2014). The prevalence of RT 245 codon polymorphisms and its association with duration of infection among HIV-1 patients in Serbia. BMC Infectious Diseases. 14(S4). 1 indexed citations
4.
Salemović, Dubravka, Djordje Jevtović, S Žerjav, et al.. (2013). Molecular typing of the local HIV-1 epidemic in Serbia. Infection Genetics and Evolution. 19. 378–385. 15 indexed citations
5.
Milošević, Ivana, Miloš Korać, S Žerjav, et al.. (2012). Non-specific inflammatory parameters in patients with pandemic H1N1 influenza. Biomedicine & Pharmacotherapy. 67(3). 218–220. 4 indexed citations
6.
Salemović, Dubravka, et al.. (2012). HIV-1 resistance profile in plasma and peripheral blood lymphocytes in a group of naive patients. Archives of Biological Sciences. 64(4). 1261–1270. 1 indexed citations
7.
Judd, Ali, Tim Rhodes, Lisa G. Johnston, et al.. (2009). Improving survey methods in sero-epidemiological studies of injecting drug users: a case example of two cross sectional surveys in Serbia and Montenegro. BMC Infectious Diseases. 9(1). 14–14. 18 indexed citations
8.
Jevtović, Djordje, et al.. (2009). The Prognosis of Late Presenters in the Era of Highly Active Antiretroviral Therapy in Serbia. PubMed. 3(1). 84–88. 5 indexed citations
9.
Jevtović, Djordje, Jovan Ranin, Dubravka Salemović, et al.. (2007). The prevalence and risk of hepatitis flares in a Serbian cohort of HIV and HCV co-infected patients treated with HAART. Biomedicine & Pharmacotherapy. 62(1). 21–25. 3 indexed citations
10.
Jevtović, Djordje, et al.. (2007). Long‐term survival of HIV‐infected patients treated with highly active antiretroviral therapy in Serbia and Montenegro. HIV Medicine. 8(2). 75–79. 7 indexed citations
11.
Jevtović, Djordje, et al.. (2005). The dissociation between virological and immunological responses to HAART. Biomedicine & Pharmacotherapy. 59(8). 446–451. 29 indexed citations
12.
Jevtović, Djordje, et al.. (2005). The prevalence and risk of immune restoration disease in HIV‐infected patients treated with highly active antiretroviral therapy. HIV Medicine. 6(2). 140–143. 118 indexed citations
13.
Stanojević, Maja, Anna Papa, Εvangelia Papadimitriou, et al.. (2002). HIV-1 Subtypes in Yugoslavia. AIDS Research and Human Retroviruses. 18(7). 519–522. 24 indexed citations
14.
Stanojević, Maja, S Žerjav, Djordje Jevtović, Dubravka Salemović, & Jovan Ranin. (2002). CMV DNA in blood and CSF of HIV infected patients. Virus Research. 85(1). 117–122. 2 indexed citations
15.
Stanojević, Maja, S Žerjav, Djordje Jevtović, & Lazar Markovic. (2000). HBsAg as the antigen component of circulating immune complexes in HIV-infected patients. Biomedicine & Pharmacotherapy. 54(3). 163–167. 12 indexed citations
16.
Stamenković, Gorana, et al.. (2000). Distribution of HCV genotypes among risk groups in Serbia. European Journal of Epidemiology. 16(10). 949–954. 16 indexed citations
17.
Stanojević, Maja, S Žerjav, Djordje Jevtović, & Lazar Markovic. (1996). Antigen/antibody content of circulating immune complexes in HIV-infected patients. Biomedicine & Pharmacotherapy. 50(10). 488–493. 9 indexed citations
18.
Delić, Dragan, et al.. (1993). Epidemiology of hepatitis D virus (delta) infection in Yugoslavia. Liver International. 13(6). 302–304. 16 indexed citations
19.
Djurković–Djaković, Olgica, et al.. (1992). No interference of rheumatoid factor(s) with toxoplasmosis IgM determination in infancy. European Journal of Pediatrics. 151(1). 42–43. 1 indexed citations
20.
Žerjav, S, et al.. (1988). Recovery from herpes simplex virus type-1 hepatitis in a female adult. Journal of Molecular Medicine. 66(17). 796–798. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026